Status:
UNKNOWN
Performance Evaluation of Artificial Intelligence Assisted Diabetic Retinopathy Grading in the Leuven University Hospital: Can Technology Improve the Resident?
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
To Evaluate the Added Value of the Use of Artificial Intelligence in the Diagnosis of Referable Diabetic Retinopathy in a Teaching Hospital Setting
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the added value of the use of artificial intelligence in the diagnosis of referable diabetic retinopathy in a teaching hospital setting
Detailed Description
Diabetes mellitus is one of the major health challenges of our era. It is estimated that 642 million people will be diagnosed with this disease worldwide by 2040. Diabetes is a disease effecting the e...
Eligibility Criteria
Inclusion
- \- Diagnosis of diabetes mellitus
- Age \> 18 years old
- Patient is capable of giving informed consent
- Fluent in written and oral Dutch, or interpreter present
Exclusion
- \- History of treatment for diabetic retinopathy or diabetic macular edema (laser or intravitreal injections)
- Participant is contraindicated for imaging by fundus imaging systems used in the study
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2022
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT05260281
Start Date
March 1 2022
End Date
November 1 2022
Last Update
March 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.